Top

Current Neurology and Neuroscience Reports

Published in:

01-09-2010 | Clinical Trial Report

Tarenflurbil in Patients with Mild Alzheimer’s Disease

Author: Karen Marder

Published in: Current Neurology and Neuroscience Reports | Issue 5/2010

Excerpt

Green RC, Schneider LS, Amato DA, et al.; for the Tarenflurbil Phase 3 Study Group: Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer’s disease: a randomized controlled trial. JAMA 2009, 302:2557–2564. …

Neugroschl J, Sano M: An update on treatment and prevention strategies for Alzheimer’s disease. Curr Neurol Neurosci Rep 2009, 9(5):368–376.CrossRefPubMed

Wilcock GK, Black SE, Hendrix SB, et al.: Efficacy and safety of tarenflurbil in mild to moderate Alzheimer’s disease: a randomised phase II trial. Lancet Neurol 2008, 7(6):483–493.CrossRefPubMed

Title: Tarenflurbil in Patients with Mild Alzheimer’s Disease
Author: Karen Marder
Publication date: 01-09-2010
Publisher: Current Science Inc.
Published in: Current Neurology and Neuroscience Reports / Issue 5/2010
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI: https://doi.org/10.1007/s11910-010-0130-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tarenflurbil in Patients with Mild Alzheimer’s Disease

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2010

Minding the Aging Brain: Technology-Enabled Cognitive Training for Healthy Elders

Emerging Oral Therapies in Multiple Sclerosis

Consent in Impaired Populations

Physical Activity and Mild Cognitive Impairment and Alzheimer’s Disease

Postural Control in Multiple Sclerosis: Implications for Fall Prevention

Quality of Life in Multiple Sclerosis: Determinants, Measurement, and Use in Clinical Practice